COPD Flashcards

1
Q

What does COPD stand for?

A

Chronic Obstructive Pulmonary Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False: The NICE guidelines recommend inhaled corticosteroids as the first-line treatment for COPD.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fill in the blank: The first-line pharmacological management for COPD includes __________.

A

Short-acting bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which class of medication is primarily used for symptom relief in COPD patients?

A

Bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two main types of bronchodilators recommended in the NICE guidelines?

A

Short-acting beta-agonists (SABAs) and long-acting beta-agonists (LABAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Multiple Choice: Which of the following is a long-acting bronchodilator? A) Salbutamol B) Formoterol C) Ipratropium

A

B) Formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: The use of antibiotics is a standard recommendation for all COPD patients.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the primary goal of pharmacological management in COPD?

A

To relieve symptoms and improve quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fill in the blank: Patients with frequent exacerbations may benefit from __________.

A

Long-acting muscarinic antagonists (LAMAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Short Answer: What is the recommended treatment for a patient experiencing a COPD exacerbation?

A

Systemic corticosteroids and antibiotics if infection is suspected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Multiple Choice: Which medication is not typically used as a first-line treatment for COPD? A) Tiotropium B) Salmeterol C) Montelukast

A

C) Montelukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

True or False: The NICE guidelines suggest that all COPD patients should be treated with oxygen therapy.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the recommended duration for systemic corticosteroid treatment during a COPD exacerbation according to NICE?

A

5 to 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fill in the blank: The use of __________ can enhance the effect of bronchodilators in COPD management.

A

Inhaled corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Short Answer: What should be monitored regularly in patients receiving long-term corticosteroid therapy?

A

Bone density and the risk of osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Multiple Choice: Which medication should be considered for patients with both COPD and asthma? A) Salbutamol B) Budesonide C) Theophylline

A

B) Budesonide

17
Q

True or False: The use of methylxanthines is a common first-line treatment for COPD.

18
Q

What is the role of mucolytics in the management of COPD according to NICE?

A

To help reduce sputum viscosity in chronic bronchitis

19
Q

Fill in the blank: Patients with a history of __________ should be assessed for the potential need for long-term oxygen therapy.

20
Q

Short Answer: What is the preferred method of delivery for inhaled medications in COPD patients?

A

Pressurized metered-dose inhalers (pMDIs) with a spacer

21
Q

Multiple Choice: Which of the following is a common side effect of long-acting beta-agonists? A) Cough B) Increased heart rate C) Nausea

A

B) Increased heart rate

22
Q

True or False: Patients with COPD should receive annual influenza vaccinations.

23
Q

What is the recommended action for patients who do not respond adequately to initial bronchodilator therapy?

A

Consider stepping up treatment to include long-acting bronchodilators

24
Q

Fill in the blank: The NICE guidelines recommend __________ for patients with severe COPD who experience frequent exacerbations.

A

Combination therapy with LABA and LAMA